Tareq Abadl/LinkedIn
Sep 4, 2026, 18:22
Tareq Abadl: The Clinical Meaning of C3 and C4
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
”Complement C3 vs C4 — Don’t Mix Them Up!
Confused about C3 vs C4 in Immunology?
Here’s the high-yield difference you need to remember:
- C3 is the major and central complement component.
- C4 is mainly associated with the Classical and Lectin pathways.
Clinical Pearl:
- Low C3 with normal C4 may suggest alternative pathway activation.
- Low C3 with low C4 may indicate classical pathway consumption.
ASCP / BOC Pearl:
- Don’t interpret complement levels alone.
- Always correlate C3, C4, and clinical findings.”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026
-
Sep 4, 2026, 21:39Pierre Sabouret: A Good Surprise Our New Publication in Life Is Online